A detailed history of Comerica Bank transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Comerica Bank holds 78 shares of ARCT stock, worth $1,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78
Previous 133 41.35%
Holding current value
$1,323
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $994 - $1,395
-55 Reduced 41.35%
78 $1,000
Q2 2024

Aug 15, 2024

SELL
$24.35 - $44.39 $17,532 - $31,960
-720 Reduced 84.41%
133 $3,000
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $4,653 - $6,405
149 Added 21.16%
853 $28,000
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $11,068 - $20,606
625 Added 791.14%
704 $22,000
Q3 2023

Nov 21, 2023

BUY
$25.44 - $37.35 $2,009 - $2,950
79 New
79 $2,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $451M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.